Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding surgery and harsh treatments.

Some people with early-stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Bhad Bhabie fired back at critics comparing her to Lil Kim and Tiny Harris, setting the record straight about her recent nose job.

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

In a recent Instagram Live session, Bhad Bhabie addressed cosmetic-surgery rumors in between her makeup routine.

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

During a major phase III trial, pembrolizumab combined with standard treatment kept cancer at bay for an average of 60 months ...

Every time I visit South Korea, where my parents emigrated from six years before I was born, I am plagued with anxieties ...